Loading…

Hologic, Inc. has signed a definitive agreement to acquire Endomagnetics Ltd, a developer of breast cancer surgery technologies, for approximately $310 million. Endomag generated about $35 million in revenue in 2023.
“We are delighted to attract the strength and focus of Hologic to power the next phase of our growth.”endomag.com
Summarized from public sources; check the original articles before acting on it.